Ausgabe 1/2013
Inhalt (30 Artikel)
Adipocyte fatty acid binding protein: a novel adipokine involved in the pathogenesis of metabolic and vascular disease?
S. Kralisch, M. Fasshauer
Effects of 12 weeks’ treatment with a proton pump inhibitor on insulin secretion, glucose metabolism and markers of cardiovascular risk in patients with type 2 diabetes: a randomised double-blind prospective placebo-controlled study
K. D. Hove, C. Brøns, K. Færch, S. S. Lund, J. S. Petersen, A. E. Karlsen, P. Rossing, J. F. Rehfeld, A. Vaag
Association of exercise-induced hyperinsulinaemic hypoglycaemia with MCT1-expressing insulinoma
J. Marquard, A. Welters, T. Buschmann, W. Barthlen, S. Vogelgesang, D. Klee, M. Krausch, A. Raffel, S. Otter, L. Piemonti, E. Mayatepek, T. Otonkoski, E. Lammert, T. Meissner
Long-term exposure to traffic-related air pollution and diabetes-associated mortality: a cohort study
O. Raaschou-Nielsen, M. Sørensen, M. Ketzel, O. Hertel, S. Loft, A. Tjønneland, K. Overvad, Z. J. Andersen
Impact of eating rate on obesity and cardiovascular risk factors according to glucose tolerance status: the Fukuoka Diabetes Registry and the Hisayama Study
T. Ohkuma, H. Fujii, M. Iwase, Y. Kikuchi, S. Ogata, Y. Idewaki, H. Ide, Y. Doi, Y. Hirakawa, N. Mukai, T. Ninomiya, K. Uchida, U. Nakamura, S. Sasaki, Y. Kiyohara, T. Kitazono
Fertility in people with childhood-onset type 1 diabetes
L. Sjöberg, J. Pitkäniemi, L. Haapala, R. Kaaja, J. Tuomilehto
Association of physical activity with all-cause mortality and incident and prevalent cardiovascular disease among patients with type 1 diabetes: the EURODIAB Prospective Complications Study
S. M. A. J. Tielemans, S. S. Soedamah-Muthu, M. De Neve, M. Toeller, N. Chaturvedi, J. H. Fuller, E. Stamatakis
Fasting plasma glucose and HbA1c in cardiovascular risk prediction: a sex-specific comparison in individuals without diabetes mellitus
B. Schöttker, H. Müller, D. Rothenbacher, H. Brenner
Impact of early detection and treatment of diabetes on the 6-year prevalence of cardiac autonomic neuropathy in people with screen-detected diabetes: ADDITION-Denmark, a cluster-randomised study
M. Charles, J. Fleischer, D. R. Witte, N. Ejskjaer, K. Borch-Johnsen, T. Lauritzen, A. Sandbaek
Diabetic retinopathy at diagnosis of type 2 diabetes in the UK: a database analysis
K. Kostev, W. Rathmann
The association of inflammatory and fibrinolytic proteins with 5 year change in insulin clearance: the Insulin Resistance Atherosclerosis Study (IRAS)
C. C. Lee, C. Lorenzo, S. M. Haffner, L. E. Wagenknecht, A. Festa, M. O. Goodarzi, D. Stefanovski, N. C. Olson, J. M. Norris, M. J. Rewers, A. J. Hanley
In vitro scan for enhancers at the TCF7L2 locus
D. Savic, S. Y. Park, K. A. Bailey, G. I. Bell, M. A. Nobrega
Production and function of IL-12 in islets and beta cells
D. A. Taylor-Fishwick, J. R. Weaver, W. Grzesik, S. Chakrabarti, S. Green-Mitchell, Y. Imai, N. Kuhn, J. L. Nadler
B lymphocyte-induced maturation protein 1 (BLIMP-1) attenuates autoimmune diabetes in NOD mice by suppressing Th1 and Th17 cells
M.-H. Lin, F.-C. Chou, L.-T. Yeh, S.-H. Fu, H.-Y. C. Chiou, K.-I. Lin, D.-M. Chang, H.-K. Sytwu
Ephedrine activates brown adipose tissue in lean but not obese humans
A. L. Carey, M. F. Formosa, B. Van Every, D. Bertovic, N. Eikelis, G. W. Lambert, V. Kalff, S. J. Duffy, M. H. Cherk, B. A. Kingwell
Direct effect of GLP-1 infusion on endogenous glucose production in humans
M. Seghieri, E. Rebelos, A. Gastaldelli, B. D. Astiarraga, A. Casolaro, E. Barsotti, A. Pocai, M. Nauck, E. Muscelli, E. Ferrannini
Poor glycaemic control in type 2 diabetes patients reduces endothelial progenitor cell number by influencing SIRT1 signalling via platelet-activating factor receptor activation
M. L. Balestrieri, L. Servillo, A. Esposito, N. D’Onofrio, A. Giovane, R. Casale, M. Barbieri, P. Paolisso, M. R. Rizzo, G. Paolisso, R. Marfella
A diabetic milieu promotes OCT4 and NANOG production in human visceral-derived adipose stem cells
P. Dentelli, C. Barale, G. Togliatto, A. Trombetta, C. Olgasi, M. Gili, C. Riganti, M. Toppino, M. F. Brizzi
Expression of the enteroviral capsid protein VP1 in the islet cells of patients with type 1 diabetes is associated with induction of protein kinase R and downregulation of Mcl-1
S. J. Richardson, P. Leete, A. J. Bone, A. K. Foulis, N. G. Morgan
A euglycaemic/non-diabetic perinatal environment does not alleviate early beta cell maldevelopment and type 2 diabetes risk in the GK/Par rat model
A. Chavey, D. Bailbé, L. Maulny, J. P. Renard, J. Movassat, B. Portha
Resveratrol prevents renal lipotoxicity and inhibits mesangial cell glucotoxicity in a manner dependent on the AMPK–SIRT1–PGC1α axis in db/db mice
M. Y. Kim, J. H. Lim, H. H. Youn, Y. A. Hong, K. S. Yang, H. S. Park, S. Chung, S. H. Koh, S. J. Shin, B. S. Choi, H. W. Kim, Y. S. Kim, J. H. Lee, Y. S. Chang, C. W. Park
Hypoglycaemia following diabetes remission in patients with 6q24 methylation defects: expanding the clinical phenotype
S. E. Flanagan, D. J. G. Mackay, S. A. W. Greeley, T. J. McDonald, V. Mericq, J. Hassing, E. J. Richmond, W. R. Martin, C. Acerini, A. M. Kaulfers, D. P. Flynn, J. Popovic, M. A. Sperling, K. Hussain, S. Ellard, A. T. Hattersley
Endoglin (CD105) is not a specific selection marker for endothelial cells in human islets of Langerhans
C. P. D. Wheeler-Jones, C. E. Clarkin, C. E. Farrar, P. Dhadda, P. Chagastelles, N. Nardi, P. M. Jones
Endoglin (CD105) is not a specific selection marker for endothelial cells in human islets of Langerhans. Reply to Wheeler-Jones CPD, Clarkin CE, Farrar CE et al [letter]
M. M. Zanone, E. Favaro, G. Camussi
Pioglitazone and risk of bladder cancer: clarification of the design of the French study. Reply to Perez AT [letter]
A. Neumann, A. Weill, P. Ricordeau, J. P. Fagot, F. Alla, H. Allemand
Erratum to: A high-fat-diet-induced cognitive deficit in rats that is not prevented by improving insulin sensitivity with metformin
A. D. McNeilly, R. Williamson, D. J. K. Balfour, C. A. Stewart, C. Sutherland